Clinical trials
Glioblastoma trials in Denmark
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 4 |
| 2012 | 1 |
| 2014 | 5 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 4 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 7 |
| Terminated | 7 |
| Active, not recruiting | 3 |
| Not yet recruiting | 2 |
| Unknown status | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rigshospitalet, Denmark | 7 |
| Hoffmann-La Roche | 3 |
| Novartis Pharmaceuticals | 3 |
| Aarhus University Hospital | 2 |
| CytoVac A/S | 2 |
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
| Karyopharm Therapeutics Inc | 2 |
| Ulrik Lassen | 2 |
| University of Aarhus | 2 |
| Anders Rosendal Korshøj | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioblastoma | 36 |
| Glioma | 6 |
| Brain Neoplasms | 4 |
| Oligodendroglioma | 4 |
| Astrocytoma | 3 |
| Brain Injuries | 2 |
| Brain Injuries, Traumatic | 2 |
| Ganglioglioma | 2 |
| Ganglioneuroma | 2 |
| Granuloma, Plasma Cell | 2 |
Trials
Showing 51 to 36 of 36. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.